Posts by Sandra Ansanay-Alex
Babies prefer human voices
The brains of 4-month-old babies respond preferentially to the human voice over sounds from their environment. This is confirmed by the results of a joint study conducted by a Sense-affiliated researcher from HES-SO Valais-Wallis. These data shed new light on the innate social nature of human beings. The voice is the most important sound…
Read MoreKickfund Ventures: CHF 70 Million for Swiss deeptech startups
The fund, backed by a diverse group of investors, including anchor investors Ernst Göhner Stiftung and Gebert Rüf Stiftung, will provide up to CHF 850,000 per company to Venture Kick alumni. Qualified investors might still be accepted to the partnership. The unique concept of the Kickfund is based on many years of experience and successful…
Read MoreGeneva Digital Health Day
The Geneva Digital Health Day is taking place on 21 May 2026 at Campus Biotech The Geneva Digital Health Day (GDHD) is a unique international conference that brings together healthcare professionals, innovators, implementers, policymakers, and academic leaders who are committed to shaping the future of Digital Health. The GDHD serves as a forward-looking platform to…
Read MoreFIT – Fondation pour l’Innovation Technologique
The Foundation for Technological Innovation offers grants and loans to support the development of innovative technological projects at various stages of their evolution. FIT supports projects in the fields of energy & environment, precision industries, nutrition & food technologies, life sciences & health, and information & digital technologies. Since 1994, more than 350…
Read MoreGENILEM
Since 1995, GENILEM helps entrepreneurs in Vaud and Geneva to build innovative and responsible businesses GENILEM supports innovative entrepreneurs, helping them to overcome today’s challenges and create sustainable solutions for tomorrow’s society. The association offers them advice, training, coaching and access to a network to increase their chances of start-up success. Founded in 1995…
Read MoreConferences
BioAlps is a partner of numerous events throughout the year and can set up events within the events, conferences, or help you identify speakers and experts. Connect in Pharma Connect in Pharma took place from 14 to 15 June 2023 in Palexpo Geneva. BioAlps organised a session on How can AI support patients…
Read MoreInvestors and Innovators Connect
Unlock New Opportunities in the Swiss Health Valley A tailor-made B2B event designed to help your company find strategic partners and investment opportunities in the Swiss Health Valley. How BioAlps Supports Your Growth BioAlps facilitates connections between companies, science parks, and research centres with potential partners, investors, or researchers interested in their projects and…
Read MoreBioAlps Deep Dive
An insightful conference or workshop on a life sciences topic Deep Dive events can take the form of conferences or workshops, with a theme on innovation, business development and services in the Health Valley. The theme is defined by an organization in the region that wishes to showcase its expertise and bring together experts on a…
Read MoreBioAlps INSIDE (4à6)
Exclusive visits and presentations of Western Switzerland life sciences companies, followed by a networking apero. Since 2010, BioAlps, in collaboration with the representatives of the economic development agencies of the 7 Western Switzerland cantons, has been organizing visits of companies, science parks and research centers. The event is intended to highlight the know-how and innovative facilities of the…
Read MoreFerring and PharmaBiome enter into a new microbiome R&D collaboration and exclusive licensing agreement
Collaboration leverages the proven development and commercial capability of Ferring with PharmaBiome’s compelling technology to research, develop and manufacture novel donor-independent microbiome-based therapies Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are announcing a research & development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology. The deal provides…
Read More